These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23702172)

  • 1. Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.
    Dierberg KL; Chaisson RE
    Clin Chest Med; 2013 Jun; 34(2):217-28. PubMed ID: 23702172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of latent tuberculosis infection in HIV infected persons.
    Akolo C; Adetifa I; Shepperd S; Volmink J
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD000171. PubMed ID: 20091503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection-related tuberculosis: clinical manifestations and treatment.
    Sterling TR; Pham PA; Chaisson RE
    Clin Infect Dis; 2010 May; 50 Suppl 3():S223-30. PubMed ID: 20397952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis, management and prevention of HIV-associated tuberculosis.
    Wasserman S; Meintjes G
    S Afr Med J; 2014 Dec; 104(12):886-93. PubMed ID: 26042273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy.
    Sacks HS
    Ann Intern Med; 2014 Sep; 161(6):JC12. PubMed ID: 25222412
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Antiretroviral Therapy for Patients with Human Immunodeficiency Virus-Associated Tuberculosis.
    Le X; Shen Y
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive treatment for tuberculosis in people with HIV.
    Swaminathan S
    Lancet; 2014 Aug; 384(9944):644-6. PubMed ID: 24835843
    [No Abstract]   [Full Text] [Related]  

  • 10. The HIV-associated tuberculosis epidemic--when will we act?
    Harries AD; Zachariah R; Corbett EL; Lawn SD; Santos-Filho ET; Chimzizi R; Harrington M; Maher D; Williams BG; De Cock KM
    Lancet; 2010 May; 375(9729):1906-19. PubMed ID: 20488516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-infection with human immunodeficiency virus and tuberculosis.
    Elston JW; Thaker HK
    Indian J Dermatol Venereol Leprol; 2008; 74(3):194-9. PubMed ID: 18583782
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons.
    Lee SS; Meintjes G; Kamarulzaman A; Leung CC
    Respirology; 2013 Aug; 18(6):912-22. PubMed ID: 23682586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    Meintjes G; Stek C; Blumenthal L; Thienemann F; Schutz C; Buyze J; Ravinetto R; van Loen H; Nair A; Jackson A; Colebunders R; Maartens G; Wilkinson RJ; Lynen L;
    N Engl J Med; 2018 Nov; 379(20):1915-1925. PubMed ID: 30428290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of interrupted anti-retroviral treatment on the reconstitution of memory and naive T cells during tuberculosis treatment in HIV patients with active pulmonary tuberculosis.
    Nalukwago S; Lancioni CL; Oketcho JB; Canaday DHE; Boom WH; Ojok L; Mayanja-Kizza H
    Afr Health Sci; 2017 Dec; 17(4):954-962. PubMed ID: 29937865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated tuberculosis: diagnostic and treatment challenges.
    El-Sadr WM; Tsiouris SJ
    Semin Respir Crit Care Med; 2008 Oct; 29(5):525-31. PubMed ID: 18810685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of latent tuberculosis infection in HIV infected persons.
    Woldehanna S; Volmink J
    Cochrane Database Syst Rev; 2004; (1):CD000171. PubMed ID: 14973947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.
    Rangaka MX; Wilkinson RJ; Boulle A; Glynn JR; Fielding K; van Cutsem G; Wilkinson KA; Goliath R; Mathee S; Goemaere E; Maartens G
    Lancet; 2014 Aug; 384(9944):682-90. PubMed ID: 24835842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated with Absence of Active Pulmonary Tuberculosis in HIV Patients with Latent Tuberculosis, Beyond Isoniazid Preventive Therapy.
    Yuniati SK; Kusmiati T
    Int J Mycobacteriol; 2024 Jul; 13(3):293-298. PubMed ID: 39277892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya.
    Gersh JK; Barnabas RV; Matemo D; Kinuthia J; Feldman Z; Lacourse SM; Mecha J; Warr AJ; Kamene M; Horne DJ
    BMC Infect Dis; 2021 Feb; 21(1):218. PubMed ID: 33632173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.